RxDoctor Payments Data

Dolapo Gbadehan, NP

Family · Atlanta, GANPI 1477252047

Payments from drug & device makers

$938in general payments, 2019–2025

Across 50 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$193
  • Astellas Pharma US Inc$116
  • Exact Sciences$98
  • AstraZeneca$91
  • Novo Nordisk$86
  • Dynavax Technologies Corporation$73
  • plus $282 from 11 others

What the payments were for

  • Food & beverage$938100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$938 in reported general payments places this provider in the 65th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$7,837
Medicare patients
46
Services billed
157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin26$38,207
JanuviaSitagliptin Phosphate29$24,077
OzempicSemaglutide22$22,569
MounjaroTirzepatide14$16,716
Diclofenac Sodium33$13,275
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,400
Lidocaine13$1,352
Levetiracetam14$687
Albuterol Sulfate HfaAlbuterol Sulfate23$587
Omeprazole34$510
Amlodipine Besylate90$492
Atorvastatin Calcium70$470
Gabapentin38$466
Hydroxyzine Hcl14$453
Metoprolol Succinate24$325

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$53$38,20726 claims
MerckJanuvia$14$24,07729 claims
Novo NordiskOzempic$86$22,56922 claims
Lilly USA, LLCMounjaro$193$16,71614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,258 family providers in Georgia.

Other family in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →